|
Karnataka calls on its pharma players to scale operations in its five designated pharma park regions
|
|
Nandita Vijayasimha, Bengaluru
November 24 , 2025
|
|
|
Karnataka government has urged pharmaceutical companies to accelerate investments and expand manufacturing capacity across its five designated pharma park regions, positioning the state as a competitive hub for drug formulation, research, and bulk production.
The state emphasized that enhanced infrastructure, and tailored incentive packages are being introduced to support rapid industry expansion. By strengthening linkages between pharma manufacturers, research institutions, and skill-development centres, Karnataka aims to create a robust ecosystem that fosters innovation and high-quality production.
These initiatives are designed not only to attract fresh domestic and global investments but also to boost the state’s contribution to India’s pharmaceutical exports and drug-discovery capabilities, said minister for large and medium industries, MB Patil and added that the earmarked zones offer ready infrastructure, policy incentives, and strong connectivity, making them primed for rapid industry-scale growth.
He informed industry representatives that significant land parcels were available for development within the Chennai–Bengaluru Industrial Corridor—360 acres in Tumakuru, 850 acres in Mulavada (phase I and 2), 763 acres in Kadachuru (Yadagiri district), and 764 acres in Yadgurki (Chitradurga district). In addition, 1,000 acres each in Srinivaspura (Kolara) and Chamarajanagara had been earmarked for pharmaceutical parks. He encouraged pharmaceutical companies to invest and establish units in these locations.
To bolster the growth of the pharmaceutical manufacturing sector in the State, the Central Government must sanction a National Institute of Pharmaceutical Sciences Education and Research (NIPER). The state government is ready to allocate land for this institute in the proposed KWIN City. A formal letter will be sent to the Centre, and discussions will follow, said Minister Patil in his discussion with the heads of pharmaceutical and biotech manufacturing companies.
Many of the companies pointed out that Karnataka’s robust pharmaceutical ecosystem enables the state to compete not only with neighbouring states but also with China. Responding to their views, the Minister assured that the government would extend all necessary support to companies looking to invest.
Companies have pointed out challenges such as the lack of housing, schools, hotels and proper access roads in certain areas. Commenting on this issue, Minister Patil said that the companies investing outside Bengaluru would receive attractive incentive packages.
The officials have been instructed to permit residential/school facilities within CA (civic amenities) sites in industrial areas. The state government is also exploring educational infrastructure on the lines of the C-CAMP (Centre for Cellular and Molecular Platforms) model. Our staff has been trained to issue approvals quickly under the single-window clearance system. These improvements would be visible within the next six months, Minister Patil assured.
In this rapid progressing digital era, Minister Patil also highlighted the growing importance of artificial intelligence in pharmaceutical manufacturing, stressing that it must be embraced. Continuous skill development and research must not be disrupted, he added. He also suggested that the pharma sector convene a meeting every six months to stay updated with new technologies and trends.
Also Minister Patil pointed out that industries in Karnataka pay only Rs. 50 per kilolitre of water, whereas neighbouring states have raised the rate to Rs. 120. To reduce operational costs, he recommended that companies in industrial areas set up common effluent treatment plants instead of maintaining individual ones.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|